The global medical plastic compounds market size
is expected to reach USD 80.40 billion by 2025, according to a new report by
Grand View Research, Inc. It is anticipated to register a CAGR of 5.2% during
the forecast period. Increasing aging population in economies such as China,
India, Germany, and Austria is projected to remain a key driving factor.
Growing demand for healthcare facilities
and services coupled with government initiatives and support towards healthcare
is projected to have a positive impact on the market growth. Increasing aging
population in countries, such as Germany, Belgium, Austria, Denmark, and Japan
is anticipated to prompt growth of the medical plastic compound market.
Increasing use of medical devices such as MRI, X-ray, robotic dispensing
systems, and apheresis machines would further drive the demand over the
forecast period.
Plastics have found a wide scope of usage
in medical and healthcare industry owing to superior properties of the product,
such as non-magnetism, impermeability, durability, and sustainability.
Radiation resistance of this plastic would offer lucrative growth opportunities
and new avenue for the manufacturers.
Surging demand for medical device plastics
in applications, including surgical instruments, catheters, disposables, bags,
implants, and drug delivery systems is anticipated to drive the demand. Rising
R&D spending to produce bio-based plastics with superior properties, such
as better quality and minimal health hazards is expected to further boost the
medical plastic compound market over the forecast period.
Stringent regulations associated with
manufacturing and disposal of waste is expected to offer lucrative growth
opportunities to the key players. Manufacturers are coming up with various
innovative ideas to improve durability and quality and to reduce the cost of
devices.
To request a sample copy
or view summary of this report, click the link below:
https://www.grandviewresearch.com/industry-analysis/medical-plastic-compounds-market
https://www.grandviewresearch.com/industry-analysis/medical-plastic-compounds-market
Further key findings from the report suggest:
· Polyethylene was the second largest product
segment, in terms of volume and accounted for over 18% market share in terms of
revenue in 2017. Increasing usage of polyethylene for manufacturing surgical
cables, artificial tendons, orthopedic sutures, and tubing is anticipated to
compliment demand.
· Asia Pacific is expected to remain the
fastest growing regional market with projected CAGR of 5.8% in terms revenue
from 2016 to 2025. Developing healthcare infrastructure and rising disposable
income in countries, such as China, India, and Japan is projected to propel the
growth
· Drug delivery system is anticipated to
register a CAGR of 5.4% in terms of revenue over the forecast period.Polymers
are widely used in drug delivery system to enhance drug stability and to
disguise the unpleasant taste of the drugs
· Major companies operating in the medical
plastic compound market include Baxter International, GW Plastics, Cyro
Industries, Becton & Dickinson, Dow Chemical, Freudenberg Medical LLC,
DuPont, ExxonMobil, Rochling Group, Medplast Inc., Nolato AB, Orthoplastics
Ltd., and Saint Gobain Performance Plastics
· Baxter International Inc., has announced to
increase production of components for disposable devices in Mountain Home, Arkansas.
Grand View Research has segmented the
global medical plastic compound market on the basis of product, application,
and region:
Medical Plastic Compounds Product Outlook
(Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·
Polyvinyl Chloride
·
Polyethylene
·
Polypropylene
·
Polystyrene
·
Polyester
·
Polycarbonate
·
Polyurethane
·
Acrylics
·
Others
Medical Plastic Compounds Application
Outlook (Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·
Disposables
·
Catheters
·
Surgical Instruments
·
Medical Bags
·
Implants
·
Drug Delivery System
·
Others
Medical Plastic Compounds Regional Outlook
(Volume, Kilo Tons; Revenue, USD Million, 2014 - 2025)
·
North America
·
Europe
·
Asia Pacific
·
CSA
·
MEA
About
Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco.
The company provides syndicated research
reports, customized research reports, and consulting services. To help
clients make informed business
decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For More Information: www.grandviewresearch.com